发明名称 FARMACEUTISKA KOMPOSITIONER OCH ANVENDNING AV DESSA
摘要 Case 118-6968 IMPROVEMENTS IN OR RELATING TO ORGANIC COMPOUNDS The thrombolytic effect of the plasminogen activator pro-urokinase is improved synergistically by the co-administration of urokinase. The two components may be administered sequentially or simultaneously, and if simultaneously, either separately or as a mixture. Preferably an initial bolus injection of urokinase is followed by an infusion of pro-urokinase.
申请公布号 SE8703788(L) 申请公布日期 1988.04.04
申请号 SE19870003788 申请日期 1987.10.01
申请人 SANDOZ AG 发明人 WELZEL D;WOLF H
分类号 A61K38/49;(IPC1-7):A61K37/54 主分类号 A61K38/49
代理机构 代理人
主权项
地址